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Abstract
Background: There is a considerable body of literature which indicates that contrast thresholds
for the detection of sinusoidal grating patterns are abnormally high in glaucoma, though just how
these elevations are related to the location of visual field loss remains unknown. Our aim,
therefore, has been to determine the relationship between contrast threshold elevation and visual
field loss in corresponding regions of the peripheral visual field in glaucoma patients.
Methods: Contrast thresholds were measured in arcuate regions of the superior, inferior, nasal
and temporal visual field in response to laser interference fringes presented in the Maxwellian view.
The display consisted of vertical green stationary laser interference fringes of spatial frequency 1.0
c deg-1 which appeared in a rotatable viewing area in the form of a truncated quadrant extending
from 10 to 20° from fixation which was marked with a central fixation light. Results were obtained
from 36 normal control subjects in order to provide a normal reference for 21 glaucoma patients
and 5 OHT (ocular hypertensive) patients for whom full clinical data, including Friedmann visual
fields, had been obtained.
Results: Abnormally high contrast thresholds were identified in 20 out of 21 glaucoma patients
and in 2 out of 5 OHT patients when compared with the 95% upper prediction limit for normal
values from one eye of the 36 normal age-matched control subjects. Additionally, inter-ocular
differences in contrast threshold were also abnormally high in 18 out of 20 glaucoma patients who
had vision in both eyes compared with the 95% upper prediction limit. Correspondence between
abnormally high contrast thresholds and visual field loss in the truncated quadrants was significant
in 5 patients, borderline in 4 patients and absent in 9 patients.
Conclusion: While the glaucoma patients tested in our study invariably had abnormally high
contrast thresholds in one or more of the truncated quadrants in at least one eye, reasonable
correspondence with the location of the visual field loss only occurred in half the patients studied.
Hence, while contrast threshold elevations are indicative of glaucomatous damage to vision, they
are providing a different assessment of visual function from conventional visual field tests.
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Background
The visual field loss caused by glaucoma has been divided
into 5 stages ranging from relative defects in sensitivity to
almost complete visual loss [1]. The pattern of loss which
alerts awareness of the disease, however, is often an arcu-
ate scotoma occurring with approximately equal fre-
quency in the superior or inferior hemifield within 20
degrees of the fovea and with or without a nasal step.
These losses are generally detected in the clinical environ-
ment by visual field tests involving presentation of spots
of light within a hemi-spherical dome at various locations
within the central visual field. However, by the time visual
field defects are detected, considerable loss of retinal gan-
glion cells may already have occurred, as exemplified by
the case of a glaucoma suspect who, despite an absence of
local field defects prior to death, showed ganglion cell
losses post-mortem of 63% and 44% in left and right reti-
nae, respectively [2]. Accordingly, there has been an impe-
tus to develop alternative tests to visual field testing
capable of detecting glaucoma at earlier stages. One such
test is the measurement of contrast sensitivity in response
to sinusoidal grating patterns generated by a variety of
methods-oscilloscope, TV or computer monitor, printed
paper, laser interferometry, or Snellen letters. The most
usual protocol has involved measurements of contrast
sensitivity in response to foveal viewing of the display [3-
14], though more involved studies have additionally
determined contrast sensitivities at peripheral locations in
the visual field [15-22]. The consensus has been, with one
exception [13], that contrast sensitivity in response to low
spatial frequencies is impaired in glaucoma, leading to
strong advocacy of its usefulness in glaucoma screening.
While most studies reported the results of visual field
tests, correlations between impaired contrast sensitivity
and the location of visual field loss were generally not
undertaken. In the one case in which this was done on a
limited scale [17], contrast sensitivity deficits were
described as occurring in both the visual hemifield show-
ing no visual loss and the hemifield which did show vis-
ual loss.
We have therefore set out to answer the question whether
regions of glaucomatous visual field loss are associated
with elevations of contrast threshold which was employed
rather than its reciprocal, the contrast sensitivity. For this
purpose, we have designed a streamlined method of
measuring contrast thresholds at different peripheral loca-
tions in the visual field based on the advantages offered by
viewing laser interference fringes in the Maxwellian view.
This provides a large visual field which can be viewed
without the need for refraction of the viewer and has a
sense of proximity, rather than the unavoidable remote-
ness of an externally generated grating display. Our results
were then compared with visual field data obtained in the
conventional manner. A preliminary report of our results
has been made previously [23].
Methods
Patients
The experiments were undertaken with the informed con-
sent of the participants and with the approval of the Ethics
Committee of the North Glasgow University Hospitals
NHS Trust and were performed in conformity with the
Declaration of Helsinki. All subjects and patients under-
went the Snellen test to determine their best visual acuity
with refraction if necessary.
A total of 26 patients ages 37 to 83 yr (mean 69 ± 10 S.D.
yr) were recruited from the Tennent Institute of Ophthal-
mology, Gartnavel General Hospital. They were diag-
nosed according to their intra-ocular pressure (IOP)
determined by applanation tonometry, the appearance of
the optic disc on ophthalmoscopic examination and the
extent of visual field loss determined with the Friedmann
Visual Field Analyzer Mark II (Clement Clarke Interna-
tional Ltd., London). Twenty one patients were diagnosed
as having glaucoma (Table 1): the most common condi-
tion was primary open angle glaucoma (POAG) in which
IOP exceeded 22 mmHg on at least 2 occasions before
treatment, there was cupping of the optic disc and visual
field defects characteristic of glaucoma were present. Nor-
mal pressure glaucoma (NPG) was diagnosed according
to the same criteria as POAG except that IOP was less than
22 mmHg. In addition, one patient had each of primary
chronic angle closure glaucoma, post-traumatic glaucoma
and sarcoid-induced glaucoma. Within the glaucoma
group, since 6 patients had a fellow eye which showed no
visual field defects or definite pathological cupping of the
optic disc and had an IOP of less than 22 mmHg, these
eyes were designated normal, though were not used as
controls. The 5 ocular hypertensives (OHT) were defined
on the basis of an IOP which exceeded 21 mmHg but with
no visual field loss and were subdivided into those with
and without pathological cupping of the optic disc (Table
1). All patients were selected on the basis of having stable
visual fields through being superimposable in terms of
their position, extent and depth, tested usually on a six
monthly basis over the 2 years preceding the study. Five
patients who were subsequently retested over intervals of
1 day to 6 months showed reproducible visual fields.
As controls, we examined 36 non-glaucoma subjects ages
48–78 yr (mean 62 ± 8 S.D. yr.) who were recruited from
within the University and from personal acquaintances.
They were deemed to be normal on the basis of a reported
absence of visual problems, a Snellen acuity of 6/6 or bet-
ter in each eye and a report of normal vision from a recent
visit to their optometrist. While 28 subjects had 2 normal
eyes, 8 subjects had one normal eye and a non-glaucoma-BMC Ophthalmology 2005, 5:22 http://www.biomedcentral.com/1471-2415/5/22
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tous problem in the fellow eye, which is dealt with sepa-
rately. Of the 36 subjects, 19 were emmetropic while the
remainder had refractive errors ranging from +1.50 DS to
-7.00 DS with astigmatism of up to +5.00 DC and all were
presbyopic to varying extents. Twenty three subjects ages
55–78 yr, including all subjects above 69 yr, were also
examined with the Central 24-2 threshold test with the
Humphrey II Visual Field Analyzer model 750 (Hum-
phrey Instruments, San Leandro, CA, USA) to which we
had ready access at times convenient to our subjects.
Apparatus
Contrast thresholds were measured with a modification of
a laser interferometer described previously [24,25] and is
shown schematically in Figure 1. Monochromatic green
light (λ = 543 nm) from a 0.95 mW He-Ne laser (Uni-
phase 1652P) was passed through a spatial filter (SF), a -
10 DS lens (L1) to expand the beam and a +10 DS lens
(L2) to collimate the beam. The beam was then divided by
a 2 inch cube beamsplitter (B1), the 2 beams reflected
from  λ/20 front silvered mirrors (M1 and M2) and
recombined by a second 2 inch cube beamsplitter (B2).
The two beams were equated in intensity by the neutral
density filter N1 and the polarization shift caused by the
Table 1: Clinical data for glaucoma and OHT patients
Pat no. Age (yr) LE 
Condition
LE VA LE VF 
loss
LE CTmax RE 
Condition
RE VA RE VF 
loss
RE CTmax I-O diff R2
1 72 POAG 6/5 74% 0.051 POAG 6/4 7% 0.023 0.025 79%*
2 73 POAG 6/6 60% 0.098 POAG 6/7.5 51% 0.168 0.045 0%°
3 67 POAG 6/6 4% 0.099 NPG 6/9 53% 0.107 0.004 48%+
4 76 POAG 6/6 7% 0.075 POAG 6/7.5 44% 0.078 0.001 1%°
5 71 POAG 6/6 36% 0.142 POAG 6/6 30% 0.067 0.045 0%°
6 66 POAG 6/6 17% 0.075 POAG 6/12 7% 0.091 0.014 -25%°
7 77 POAG 6/24 55% 0.055 POAG 6/6 67% 0.044 0.012 14%°
8 68 POAG 6/6 23% 0.069 normal 6/5 4% 0.049 0.019 55%*
9 75 POAG 6/9 44% 0.102 normal 6/5 1% 0.041 0.034 85%*
10 72 normal 6/6 2% 0.023 POAG 6/9 42% 0.031 0.006 47%+
11 37 POAG 6/18 14% 0.089 blind nil 100% n/s na na
12 83 POAG pxf 6/9 1% 0.066 POAG pxf 6/9 51% n/s na na
13 83 POAG pxf 6/18 69% 0.058 POAG pxf 6/12 46% 0.074 0.025 -24%°
14 74 POAG pxf 6/5 26% 0.067 OHT 6/6 3% 0.056 0.008 9%°
15 73 NPG 6/5 17% 0.055 NPG 6/5 47% 0.033 0.014 0%°
16 76 NPG 6/9 18% 0.150 NPG 6/12 47% 0.060 0.021 46%+
17 73 NPG 6/9 53% 0.048 normal 6/9 4% 0.027 0.010 49%+
18 54 RD 6/12 2% 0.046 NPG 6/5 41% 0.083 0.023 85%*
19 61 PCACG 6/9 11% 0.078 ACG 6/9 3% 0.072 0.012 na
20 79 PTG 6/9 55% 0.147 normal 6/9 6% 0.077 0.055 26%°
21 55 normal 6/6 7% 0.044 SIG 6/6 52% 0.058 0.017 73%*
22 70 OHT 6/5 0%(2%) 0.031 OHT 6/5 0% (6%) 0.018 0.002 na
23 78 OHT 6/5 0% (7%) 0.022 OHT 6/9 3% (8%) 0.033 0.0064 na
24 57 OHT 6/5 6% (13%) 0.054 OHT 6/5 4%(13%) 0.051 0.0006 na
25 62 OHT 6/5 2% (2%) 0.034 OHT pdc 6/12 4% (6%) 0.042 0.010 na
26 72 A OHT 
pdc
6/60 8% (29%) 0.155 OHT pdc 6/12 8% (35%) 0.059 0.068 na
Pat no. Patient number, LE left eye, RE right eye, A amblyopic, CTmax highest contrast threshold value (to be compared against the upper prediction 
limit of 0.045), I-O diff inter-ocular difference (to be compared against the upper prediction limit of 0.006), NPG normal pressure glaucoma, OHT 
ocular hypertensive, na not applicable, n/s not seen, PCACG primary chronic angle closure glaucoma, pdc pathological cupping of optic disc, POAG 
primary open angle glaucoma, PTG post-traumatic glaucoma, pxf pseudoexfoliation, RD retinal detachment, SIG sarcoid-induced glaucoma, VA 
visual acuity, VF visual field. Negative R2 values denote inverse relationship. *p < 0.05, +0.05 <p < 0.10, °p > 0.10. Some eyes denoted normal show 
visual field loss due to the blind spot while some glaucomatous eyes showing minimal visual loss had additional loss either more peripheral or more 
central to the truncated quadrant. OHT patients also show visual field loss score in parenthesis at 12 months follow-up examinations.BMC Ophthalmology 2005, 5:22 http://www.biomedcentral.com/1471-2415/5/22
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beamsplitters was compensated by the rotatable sheet
polarizer (P1, extinction = 10-4). The combined beams
were passed through a second polarizer (P2) to sharpen
the polarization prior to combination at the plate beam-
splitter B3 with the background beam which consisted of
non-coherent light from a tungsten filament microscope
lamp. The latter beam was passed through heat absorbing
filters, a green interference filter (C, peak λ = 546 nm), a
polarizer (P3) to polarize the light at 90° to the laser
beams and a neutral density filter (N2) to equate the
intensity to that of the laser beams. The combined laser
and background beams were passed through a rotatable
polarizer of 2 inch diameter (P4, Coherent-Ealing 22-
9161). The emergent beam passed through an iris dia-
phragm (I) which controlled the overall field size, an
aperture consisting of a rotatable truncated quadrant (Q)
and the Maxwellian lens assembly which consisted of 38
mm diameter +20 DS plano-convex and +32 DS biconvex
Schematic representation of optical apparatus used to generate vertical sinusoidal laser interference fringes which are  observed in the Maxwellian view Figure 1
Schematic representation of optical apparatus used to generate vertical sinusoidal laser interference fringes which are 
observed in the Maxwellian view. Abbreviations: A aperture, B beam splitter, C interference filter, I iris diaphragm, L lens, M 
front silvered mirror, N neutral density filter, P polarizer, SF spatial filter. Further explanation is given in Methods.BMC Ophthalmology 2005, 5:22 http://www.biomedcentral.com/1471-2415/5/22
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high refractive index lenses mounted in the same housing
as the rotatable aperture. The total power of the Max-
wellian lens assembly was +42 DS. The subject or patient
looked into the Maxwellian lens with the chin supported
by a chin rest. The observed visual display consisted of an
attenuated green central fixation light of subtense 2° and
the truncated quadrant which was rotatable to the 4 cho-
sen visual field positions viz. temporal, superior, inferior
and nasal, as shown for right eye viewing in Figure 2.
The truncated quadrant extended from 10° to 20° from
the central fixation point. The angular dimensions were
calibrated from determination of the location of the nasal
and temporal margins of the blind spot from the axis of
fixation. These were determined first in angular subtenses
for viewing a sheet of graph paper from 25 cm. The linear
dimensions of the blind spot from the axis of fixation
were then obtained for viewing a needle mounted on a
micrometer, coplanar with the iris diaphragm, through
the Maxwellian lens. The factor to convert linear dimen-
sions into angular dimensions was then used to convert
the linear dimension of the Maxwellian display into angu-
lar subtenses. The procedure was undertaken in both eyes
in 3 subjects with close agreement between the results.
By translation of mirror M1 to increase the pathlength of
the laser beam reflected from M1, interference fringes
were generated at a spatial frequency directly related to the
pathlength difference. By adjustment, the spatial fre-
quency was set to 1.0 c deg-1 which is readily detected for
peripheral viewing at our eccentricities [26]. The contrast
of the display was varied by rotation of the polarizer P4,
since contrast is proportional to sin2θ where θ is the angle
of rotation from the position of zero contrast. The inten-
sities of the laser beam and background beam were
equated using a UDT S370 Optometer at the position of
the eye. Likewise, the intensities of the 4 quadrants were
also equalized. The final viewing intensity was deter-
mined psychophysically to be 3.2 log units above foveal
threshold.
Contrast threshold determinations
Prior to the determinations, each subject or patient was
given a standard explanation with the aid of diagrams as
to the nature of the test, which was then carried out under
standardized subdued illumination. The subject or
patient viewed the display through the Maxwellian lens
without external refraction. With the direction of gaze
determined by the central fixation spot, the subject or
patient increased the contrast of the grating display in the
peripherally-located truncated quadrant until the pattern
became just visible and no more. This gives results for
contrast thresholds similar to those for the more time con-
suming 50% of seeing [27]. The angle of rotation was
recorded and readings repeated. First, the subject or
patient had practice runs with the truncated quadrant in
each of its 4 positions. This was then followed by 6 con-
trast threshold determinations for each of the 4 truncated
quadrant positions for each eye in turn. The tests includ-
ing the preliminary Snellen test and explanation took 20–
40 min to complete. Repeat determinations in 2 normal
subjects and one glaucoma patients on different days con-
firmed the consistency of the contrast threshold values.
The determinations for the glaucoma patients were under-
taken prior to the release of the visual field charts for anal-
ysis and the time interval between the tests ranged from
the same day to 36 weeks (mean 64 ± 55 S.D. days).
Data analysis
Statistical analyses were undertaken with the Minitab sta-
tistical package [28]. The basic method of analysis
involved the calculation of 95% prediction limits for the
contrast thresholds and for the inter-ocular differences in
contrast threshold between companion normal eyes,
Schematic representation of the truncated quadrants in the temporal, superior, inferior and nasal positions as seen by the right  eye Figure 2
Schematic representation of the truncated quadrants in the temporal, superior, inferior and nasal positions as seen by the right 
eye. The central fixation light was of subtense 2 deg and the truncated quadrant extended from 10–20 deg. The sinusoidal 
interference fringe pattern had a spatial frequency of 1.0 c deg-1.BMC Ophthalmology 2005, 5:22 http://www.biomedcentral.com/1471-2415/5/22
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against which the results for the glaucoma patients were
compared. After conversion of the data to cumulative
probabilities, the sensitivity (the percentage of correctly
classified glaucoma patients) was plotted against 1 – spe-
cificity (the percentage of incorrectly classified normal
subjects) to obtain the Receiver Operating Characteristic
(ROC) curve [29,30]. The area under the ROC curve is a
measure of the sensitivity over a range of criterion levels
and varies from 0.5 when there is an equal likelihood of
glaucoma patients and normal subjects exceeding the
specified criterion to 1.0 when there is perfect discrimina-
tion of glaucoma patients from normal subjects.
Comparisons between the mean contrast threshold for
each truncated quadrant against visual field loss were
undertaken by linear regression analysis after quantifying
the visual field loss from the patient's Friedmann visual
field chart [31]. A template containing an aperture corre-
sponding to the dimensions of the truncated quadrant
was laid over the Friedmann visual field chart and the fol-
lowing scores allocated to each point tested according to
whether the point was visible through the applied neutral
density filter: 3 – densest filter appropriate to age (usually
1.2 log units attenuation), 2 – next densest filter (usually
0.8 log units attenuation), 1 – no filter and 0 – not visible.
The summed values were expressed as a percentage of the
maximum possible score for that truncated quadrant and
the difference from 100% was the visual field loss score.
This was repeated for each of the 4 positions shown in Fig-
ure 2 and no allowance was made for the presence of the
blind spot in the temporal quadrant. From the regression
analysis, the value of R2, the coefficient of determination,
was obtained. This gives as a percentage the amount of the
variation in contrast threshold against visual field loss
score which is accounted for by the line of best fit (regres-
sion line); so R2 ranges from 0% when the data are ran-
domly distributed to 100% when the data points fall
exactly on the regression line. The value of R2 is amenable
to statistical testing and significance was taken as p < 0.05.
Results
Control group
The contrast thresholds for the 64 normal eyes were nor-
mally uniformly low for each of the superior, temporal,
inferior and nasal truncated quadrants with no significant
differences between the mean values of the 4 quadrants (p
= 0.81). The mean contrast threshold and the 95% upper
prediction limit were then calculated for the 4 truncated
quadrants for the normal eyes of the group of 8 subjects
together with one eye chosen at random from the remain-
ing 28 subjects to give equal numbers of left and right
eyes. The contrast threshold values for the group con-
formed closely to a normal distribution and had a mean
value of 0.027 ± 0.011 S.D. contrast units, giving a 95%
upper prediction limit of 0.045 contrast units. Inter-ocu-
lar comparisons were made between the mean values for
left and right eyes in the group of 28 subjects with 2 nor-
mal eyes. The mean of the modulus of the difference was
0.0029 ± 0.0020 S.D. contrast units, giving a 95% upper
prediction limit of 0.0060 contrast units. These upper pre-
diction limits were then used to assess the contrast thresh-
olds of the glaucoma patients and of the abnormal eyes of
the non-glaucoma group.
The Humphrey Central 24-2 test for the 40 normal eyes in
23 subjects (the remaining 6 eyes had non-glaucomatous
abnormalities), missed 5 blindspots, gave mean devia-
tions outside normal limits in 8 eyes and gave abnormal
or borderline results with the glaucoma hemifield test in
12 eyes. In all cases, the abnormal results were explained
by drooping eyelids, obstruction by spectacles or trial
frames and subject error, which are common hazards of
automated perimetry [32].
Glaucoma patients
The first comparison was to determine the extent to which
the contrast threshold for a truncated quadrant exceeded
the upper prediction limit of 0.045 contrast units, irre-
spective of the location of the quadrant. Abnormally high
values occurred in 29 out of 33 glaucomatous eyes (87%)
and, on a patient by patient basis, in 20 out of 21 patients
(95%). There were no apparent differences among the dif-
ferent types of glaucoma (Table 1). Examples of patients
with elevated contrast thresholds are shown in Figures 3
&4.
Second, a comparison was made of the modulus of the
inter-ocular difference of the mean contrast threshold for
left and right eyes against the upper prediction limit of
0.0060 contrast units. This was abnormally high in 18 out
of 20 glaucoma patients (90%) for whom the comparison
was possible, including the patient with bilateral normal
contrast thresholds. However, when identification was
made on the basis of the combination of either an abnor-
mal contrast threshold or abnormal inter-ocular differ-
ence, 100% correct identification was achieved. The
optimal sensitivity and specificity and the area under the
ROC curve are given in Table 2 which also shows data for
tests of contrast threshold restricted to the superior and
inferior truncated quadrants and to the nasal and tempo-
ral truncated quadrants. Both these assessments show
reduced sensitivity compared with testing of all 4 trun-
cated quadrants. It is thus clear contrast threshold eleva-
tions, especially in combination with intra-ocular
differences were effective in detecting glaucoma.
OHT patients
In the 5 OHT patients, contrast thresholds were elevated
in 4 out of 10 eyes, corresponding to 2 patients, with no
differences between those with and without pathologicalBMC Ophthalmology 2005, 5:22 http://www.biomedcentral.com/1471-2415/5/22
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Patient 9 (Table 1) A & B Histograms of contrast threshold (mean ± S.E.M.) for superior (s), temporal (t), inferior (i) and nasal  (n) truncated quadrants in the left and right eyes showing upper 95% prediction limit of 0.045 contrast units as broken horizon- tal line Figure 3
Patient 9 (Table 1) A & B Histograms of contrast threshold (mean S.E.M.) for superior (s), temporal (t), inferior (i) and nasal (n) 
truncated quadrants in the left and right eyes showing upper 95% prediction limit of 0.045 contrast units as broken horizontal 
line. Contrast thresholds were abnormal in the left eye. C & D Friedmann visual fields showing: unmarked letters-normal 
detection (1.2 logarithmic units attenuation), reduced sensitivity (❍  0.8 logarithmic units attenuation and ø zero attenuation) 
and ●  zero detection. The main visual field loss was in the inferior hemifield of the left eye. E Contrast threshold against visual 
field loss score taken from Friedmann charts for each truncated quadrant, showing best fitting relationship as broken line. Rela-
tionship was significant: R2 = 85%, p = 0.001.
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Patient 6 Figure 4
Patient 6. Same conventions as in Figure 3 but with ❍  as 1.0 logarithmic units attenuation. A & B Contrast thresholds were 
abnormal in left and right eyes. C & D Visual field loss was diffuse in the left eye and occurred in inferior temporal quadrant of 
right eye. E Relationship between contrast threshold and visual field loss score was not significant: R2 = 25%, p = 0.12.
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cupping of the optic disc. The inter-ocular difference was
elevated in 3 out of 5 OHT patients. Follow-up of the OHT
patients over the next 12 months showed that those with
normal contrast thresholds retained normal visual fields
while the 2 patients with elevated thresholds developed
marked visual field loss in both eyes (Table 1).
Comparison of locations of contrast threshold elevation 
and visual field loss
Our main assessment was to determine whether those
parts of the visual field which showed abnormally high
contrast thresholds also corresponded to the location of
the visual field loss. This was undertaken by regression
analysis of contrast threshold against the corresponding
visual field loss score for each of the truncated quadrants
in both eyes. In order to achieve a reasonable distribution
of data points, patients were required to have a range of
visual field loss scores in excess of 20% together with an
absence of visibility in no more than one of the truncated
quadrants. This provided 18 glaucoma patients whose
results are shown in Table 1. Contrast threshold and vis-
ual field loss were strongly related in 5 patients (R2 = 55–
85%, p < 0.05) as illustrated by Figure 3, showed a sem-
blance of s direct relationship in 4 patients (R2 = 46–49%,
0.05 <p < 0.10) and showed an absence of a relationship
in 9 patients (R2 = 0–26%, p > 0.1) as illustrated by Figure
4. There was no correlation between the form of the rela-
tionship and the type of glaucoma (Table 1). We also
repeated the analysis in 8 patients with minimal visual
field loss in one eye for which a single mean value was cal-
culated (i.e. giving n = 5 for regression analysis). The R2
values were unaffected in the new analysis (p  = 0.84,
paired t-test) and a significant or borderline relationship
was still present in 5 patients.
Control subjects with abnormal fellow eye
There were 8 subjects in the non-glaucoma control group
with an abnormality of one eye. In the subject with the ret-
inal scar, the contrast thresholds were elevated in the trun-
cated quadrant containing the scar as confirmed by the
Humphrey Visual Field. On the other hand, the contrast
thresholds for the subjects with repaired retinal detach-
ment, mild cataract and solar damage and for 2
amblyopes were normal. The third amblyope had abnor-
mally high contrast thresholds while the subject with
macular degeneration was unable to fixate with that eye.
Discussion
Contrast thresholds were readily measured with our Max-
wellian view interferometer in normal subjects, even in
the presence of refractive errors as large as -7.00 DS and
+5.00 DC, which is a positive advantage over externally
viewed displays which depend on the accuracy of the
refraction and factors like spectacle slippage or obstruc-
tion by the edges of frames. In a limited number of cases,
contrast thresholds were readily obtained in the presence
of minor lens opacities and in amblyopes, though the
method is impracticable in cases where fixation cannot be
achieved. Generally, the contrast thresholds of normal
subjects were uniformly low. While evidence of the blind
spot in the form of elevated contrast thresholds in the
temporal truncated quadrant occurred infrequently, this
was probably the result of stimulation of a large area of
retina compared with the well circumscribed extent of the
blind spot of which there is a perceptual lack of awareness
[33]. The use of relatively large truncated quadrants may
suggest intuitively that localisation of visual loss was
being sacrificed though there is evidence to suggest that
this is not the case. Threshold values between neighbour-
ing test points tend to be correlated with the result that the
central visual field is organized into discrete clusters or
sectors which are related to the projection of retinal gan-
glion cell axons [34,35]. Another issue is the variation in
the number of cycles between superior/inferior and nasal/
temporal truncated quadrants. We chose the stimulus spa-
tial frequency to be 1.0 c deg-1 to ensure high sensitivity in
the peripheral retina [26] and a number of cycles which
did not limit sensitivity, at least for foveal viewing [36]. It
is conceivable that, at a peripheral location, differences in
the number of cycles may affect contrast sensitivity
though such an effect is likely to be small [37]. Frequency
Doubling Technology (FDT) perimetry employs stimulus
fields not dissimilar to those employed in the present
study though the grating pattern is phase modulated at a
Table 2: Signal detection data
Criterion n Sensitivity Specificity Area under ROC
CTmax by eye 33 93.9% 91.0% 0.956
CTmax S/I 33 87.8% 91.0% 0.953
CTmax N/T 33 81.8% 91.0% 0.923
CTmax by patient 21 90.4% 95.0% 0.954
I-O diff 20 89.5% 85.7% 0.897
CTmax or I-O diff 20 95.0% 100% 0.993
CTmax highest contrast threshold value, S/I superior and inferior truncated quadrants, N/T nasal and temporal truncated quadrants, I-O diff inter-
ocular difference.BMC Ophthalmology 2005, 5:22 http://www.biomedcentral.com/1471-2415/5/22
Page 10 of 12
(page number not for citation purposes)
high temporal frequency to produce an illusory doubling
of the spatial frequency [38]. Reduction of the dimension
of the square stimulus field from 10° to 4° produced only
a modest increase in contrast threshold [39]. These results
are thus not inconsistent with the absence of a significant
differences between the contrast thresholds for the differ-
ent truncated quadrants.
In terms of correct identification of our glaucoma
patients, contrast thresholds were elevated in one or more
truncated quadrants in all but one of our 21 patients while
inter-ocular differences were elevated in all but 2 out of 20
patients, which is consistent with previous studies [4,15-
18,21]. These elevations were present irrespective of the
type of glaucoma, which is consistent with a common
mechanism for ganglion cell loss in chronic glaucoma
[40]. In terms of detection of glaucoma, our method has
performed soundly with an area under the ROC curve of
0.956 which compares well with other methodologies
employed in the early detection of glaucoma viz. short
wave length automated perimetry (SWAP), frequency
doubling technology, resolution acuity perimetry, detec-
tion acuity perimetry and temporal modulation perimetry
[41] and considerably better than for contrast sensitivities
with central viewing [42]. Of especial interest was the per-
formance of our test with the OHT patients. Initially, it
seemed that two patients would be incorrectly diagnosed
in both eyes which had markedly elevated contrast
thresholds; however within the next 12 months they each
developed appreciable visual field loss in their eyes (Table
1). While the sample size is small, it indicates a potential
predictive function which has also been described for
FDT, high-pass resolution perimetry and SWAP [43,44]. A
further improvement in the area under the ROC curve to
0.993 occurred when the assessment of contrast thresh-
olds was combined with that of the inter-ocular difference
in contrast threshold. This is a simple extension of the
analysis which uses pre-existing data and its value has
been remarked upon previously [38].
The central aim of our study, however, was whether the
contrast threshold results reflected the amount of visual
field loss in the same region of the visual field. While there
was a reasonable correspondence in 50% of our 18 glau-
coma patients (Figure 3), in the other half of the patients,
there was a marked mismatch so that some patients had
normal contrast thresholds in quadrants showing high
visual field loss while others had elevated contrast thresh-
olds in seemingly normal parts of the visual field (Figure
4). We are confident that the results were not caused by
abrupt shifts of visual field loss between quadrants since
the visual fields were stable over the 2 years preceding our
tests and indeed subsequent to our tests. While automated
perimetry is widely used to ascertain visual field loss, our
preference was firmly for the Friedmann test on the basis
that it was less disconcerting to elderly patients and is con-
sistent with the transferability of visual field data between
different machines [45]. While our identification of the
misalignment with visual field loss relates to the detection
of a stationary grating pattern, allusions have also been
made to FDT error scores which occurred in the hemifield
opposite to that containing the visual field loss [46,47].
This lack of correspondence between contrast threshold
elevation and visual field loss can reasonably be attrib-
uted to the different attrition rates for the different modal-
ities of visual function in different individuals which is
well known in glaucoma [12,38,48-53]. To this, we can
further add that different modalities, at least in terms of
light detection and contrast detection, are affected differ-
ently in different parts of the retina. The sentiment has
been expressed that it does not matter whether two tests
do not agree so long as the disease is detected during
screening [47]. To an extent this is understandable though
it would clearly be desirable to have a rational basis for
whatever testing regime is adopted. One possible explana-
tion is that conventional perimetry detects light detection
defects [54] while tests like FDT, SWAP and contrast
threshold measurements detect different manifestations
of ganglion cell damage [40,41]. Certainly there are sev-
eral tests, particularly FDT and SWAP, which could be
used profitably alongside visual field testing [48] and, to
these, contrast threshold determinations in the peripheral
visual field may be added.
Conclusion
Our results therefore do confirm that contrast thresholds
in response to sinusoidal grating patterns presented to
peripheral regions of the visual field are invariably abnor-
mally elevated in cases of glaucomatous visual field loss.
The regions of threshold elevations, however, did not map
onto the regions of visual field loss, which indicates con-
trast threshold testing cannot be considered as a substitute
for visual field tests. It may however provide valuable sup-
plementary information which may be obtained simply
and rapidly with the type of interferometric apparatus we
have described.
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